| Institution: | 1. Department of Pharmaceutical Chemistry, Drug Analysis and Drug Information, Center for Neurosciences, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium;2. Department of Pharmaceutical Biotechnology and Molecular Biology, Center for Neurosciences, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium;1. Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, 250 College Street, M5T 1R8 Toronto, Ontario, Canada.;2. Department of Psychiatry, University of Toronto, 250 College Street, M5T 1R8 Toronto, Ontario, Canada;3. Department of Neuropsychiatry, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, 160-8582 Tokyo, Japan;4. Geriatric Mental Health Division, Centre for Addiction and Mental Health, 80 Workman Way, M6J 1H4 Toronto, Canada;5. Institute of Medical Science, University of Toronto, 1 King''s College Circle, M5S 1A8 Toronto, Ontario, Canada;6. Campbell Research Institute, Centre for Addiction and Mental Health, 1001 Queen St. W, M6J 1H4 Toronto, Ontario, Canada;1. Research Imaging Centre, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario M5T 1R8, Canada;2. Institute of Medical Science, University of Toronto, 2374 Medical Sciences Building, 1 King''s College Circle, Toronto, Ontario M5S 1A8, Canada;3. Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario M5T 1R8, Canada |
